Stemline Therapeutics, Inc. Stock
Equities
US85858C1071
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Ivan Bergstein
CEO | Chief Executive Officer | 58 | 03-08-07 |
David Gionco
DFI | Director of Finance/CFO | 63 | 14-01-15 |
Jeffrey Levitt
CMP | Compliance Officer | - | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ivan Bergstein
CEO | Chief Executive Officer | 58 | 03-08-07 |
1st Jan change | Capi. | |
---|---|---|
-3.30% | 102B | |
+1.79% | 96.84B | |
-0.44% | 21.48B | |
-18.35% | 20.82B | |
-7.45% | 18.6B | |
-40.31% | 16.81B | |
-26.84% | 13.78B | |
+0.59% | 13.4B | |
+20.86% | 11.06B |